Abstract:Objective: The aim of this study was to provide geographic comparisons of deep brain stimulation (DBS) procedures in Latin America with the US and Europe regarding primary indications, demographic information, clinical and device-related adverse events, technology used, and patient outcomes using the Medtronic Product Surveillance Registry data as of July 31, 2021. Methods: Two thousand nine hundred twelve patients were enrolled in the registry (2782 received DBS and 1580 are currently active). Fourteen countries contributed 44,100 years of device experience to the registry. DBS centers in Latin America are located in Colombia (n = 3), Argentina (n = 1), Brazil (n = 1), and Mexico (n = 1). Fisher's exact test was used to compare the difference in proportions of categorical variables between regions. The Wilcoxon signed-rank test was used for the EQ-5D index score change from baseline to follow-up. Results: The most common indication for DBS was Parkinson's disease across all regions. In Latin America, dystonia was the second most common indication, compared to essential tremor in other regions. There was a striking finding with respect to age-patients were an average of 10 years younger at DBS implantation in Latin America. This difference was most likely due to the greater number of patients with dystonia receiving the device implants. The intraoperative techniques were quite similar, showing the same level of quality and covering the main principles of the surgeries with some variations in the brand of frames, planning software, and microrecording systems. Rechargeable batteries were significantly more common in Latin America (72.37%) than in the US (6.44%) and Europe (9.9%). Staging of the DBS procedure differed, with only 11.84% in Latin America staging the procedure compared with 97.58% and 34.86% in the US and Europe, respectively. The EQ-5D score showed significant improvements in all regions during the first 6-12 months (p < 0.0001). However, the 24-month follow-up only showed an improvement in the scale for Latin America (p < 0.0001). Conclusions: DBS was performed in Latin America with similar indications, techniques, and technology as in the US and Europe. Important differences were found, with Latin America implementing more regular use of rechargeable devices, including younger patients at the time of surgery, and showing more sustained quality of life improvements at 24 months of follow-up. The authors hypothesize that these disparities stem from differences in resources among regions. However, more studies are needed to standardize DBS practice across the world to improve patients' quality of life and provide high-quality care.

An International Survey of Deep Brain Stimulation Utilization in Asia and Oceania: The DBS Think Tank East

2.322 DEEP BRAIN STIMULATION IN CHINA: PRESENT AND FUTURE

New insights from a Malaysian real-world deep brain stimulation cohort

Deep Brain Stimulation Initiative: Toward Innovative Technology, New Disease Indications, And Approaches To Current And Future Clinical Challenges In Neuromodulation Therapy

Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in Optogenetics, Ethical Issues Affecting DBS Research, Neuromodulatory Approaches for Depression, Adaptive Neurostimulation, and Emerging DBS Technologies

New Frontiers for Deep Brain Stimulation: Directionality, Sensing Technologies, Remote Programming, Robotic Stereotactic Assistance, Asleep Procedures, and Connectomics

The Present Indication and Future of Deep Brain Stimulation

Deep brain stimulation in Latin America in comparison with the US and Europe in a real-world population: indications, demographics, techniques, technology, and adverse events

Technology of deep brain stimulation: current status and future directions

Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy

Deep brain stimulation for Parkinson’s disease: bibliometric analysis of the top 100 cited literature

Survey of common deep brain stimulation programming practices by experts in Parkinson's Disease

Clinical neuromodulatory effects of deep brain stimulation in disorder of consciousness: A literature review

Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson's Disease

Deep brain stimulation for movement disorders treatment in Africa: The current status, outcomes, and challenges

Deep Brain Stimulation Telemedicine Programming During the COVID-19 Pandemic: Treatment of Patients with Psychiatric Disorders

Probing responses to deep brain stimulation with functional magnetic resonance imaging

Proceedings of the Ninth Annual Deep Brain Stimulation Think Tank: Advances in Cutting Edge Technologies, Artificial Intelligence, Neuromodulation, Neuroethics, Pain, Interventional Psychiatry, Epilepsy, and Traumatic Brain Injury

Advances in Technical Aspects of Deep Brain Stimulation Surgery

Utility of Deep Brain Stimulation Telemedicine for Patients With Movement Disorders During theCOVID-19 Outbreak in China

Adaptive Deep Brain Stimulation in Parkinson′s Disease: A Delphi Consensus Study